[To the problem of the control of organotropism].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001168:Arthritis; D004357:Drug Synergism; D005122:Exudates and Transudates / Q000032:analysis; D005557:Formaldehyde / Q000494:pharmacology; D007719:Knee Joint / Q000187:drug effects*; D009566:Nitrates; D010539:Permeability; D010653:Phenylbutazone / Q000494:pharmacology* / Q000627:therapeutic use; D010994:Pleura / Q000187:drug effects*; D010998:Pleurisy / Q000188:drug therapy*; D011817:Rabbits; D051381:Rats; D013331:Strychnine / Q000633:toxicity; D013424:Sulfanilamides / Q000032:analysis / Q000097:blood; D013431:Sulfates; D013432:Sulfathiazoles / Q000032:analysis / Q000097:blood; D015032:Zinc / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D009566:Nitrates; D013424:Sulfanilamides; D013431:Sulfates; D013432:Sulfathiazoles; D005557:Formaldehyde; D010653:Phenylbutazone; D013331:Strychnine; D015032:Zinc
K probleme upravleniia organotropizmom.